239 related articles for article (PubMed ID: 10466635)
1. A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors.
Mizuguchi H; Kay MA
Hum Gene Ther; 1999 Aug; 10(12):2013-7. PubMed ID: 10466635
[TBL] [Abstract][Full Text] [Related]
2. Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3.
Gorziglia MI; Lapcevich C; Roy S; Kang Q; Kadan M; Wu V; Pechan P; Kaleko M
J Virol; 1999 Jul; 73(7):6048-55. PubMed ID: 10364357
[TBL] [Abstract][Full Text] [Related]
3. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
Ji L; Bouvet M; Price RE; Roth JA; Fang B
Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089
[TBL] [Abstract][Full Text] [Related]
4. Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII.
Andrews JL; Kadan MJ; Gorziglia MI; Kaleko M; Connelly S
Mol Ther; 2001 Mar; 3(3):329-36. PubMed ID: 11273775
[TBL] [Abstract][Full Text] [Related]
5. An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors.
Catalucci D; Sporeno E; Cirillo A; Ciliberto G; Nicosia A; Colloca S
J Virol; 2005 May; 79(10):6400-9. PubMed ID: 15858023
[TBL] [Abstract][Full Text] [Related]
6. Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants.
Krougliak V; Graham FL
Hum Gene Ther; 1995 Dec; 6(12):1575-86. PubMed ID: 8664382
[TBL] [Abstract][Full Text] [Related]
7. Generation of recombinant adenovirus vector with infectious adenoviral genome released from cosmid-based vector by simple procedure allowing complex manipulation.
Kojima H; Ohishi N; Yagi K
Biochem Biophys Res Commun; 1998 May; 246(3):868-72. PubMed ID: 9618304
[TBL] [Abstract][Full Text] [Related]
8. Improved adenoviral vector for vascular gene therapy : beneficial effects on vascular function and inflammation.
Qian HS; Channon K; Neplioueva V; Wang Q; Finer M; Tsui L; George SE; McArthur J
Circ Res; 2001 May; 88(9):911-7. PubMed ID: 11349000
[TBL] [Abstract][Full Text] [Related]
9. New tools for the generation of E1- and/or E3-substituted adenoviral vectors.
Danthinne X; Werth E
Gene Ther; 2000 Jan; 7(1):80-7. PubMed ID: 10680020
[TBL] [Abstract][Full Text] [Related]
10. Effects of first generation E1E3-deleted and second generation E1E3E4-deleted/modified adenovirus vectors on human endothelial cell death.
Jornot L; Petersen H; Lusky M; Pavirani A; Moix I; Morris ; Rochat T
Endothelium; 2001; 8(3):167-79. PubMed ID: 11824470
[TBL] [Abstract][Full Text] [Related]
11. Selective gene transfer into the liver of non-human primates with E1-deleted, E2A-defective, or E1-E4 deleted recombinant adenoviruses.
Raper SE; Haskal ZJ; Ye X; Pugh C; Furth EE; Gao GP; Wilson JM
Hum Gene Ther; 1998 Mar; 9(5):671-9. PubMed ID: 9551615
[TBL] [Abstract][Full Text] [Related]
12. Hybrid yeast-bacteria cloning system used to capture and modify adenoviral and nonviral genomes.
Hokanson CA; Dora E; Donahue BA; Rivkin M; Finer M; Mendez MJ
Hum Gene Ther; 2003 Mar; 14(4):329-39. PubMed ID: 12659674
[TBL] [Abstract][Full Text] [Related]
13. A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4.
Brough DE; Lizonova A; Hsu C; Kulesa VA; Kovesdi I
J Virol; 1996 Sep; 70(9):6497-501. PubMed ID: 8709289
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of CXCR4 gene expression in primary human endothelial cells following infection with E1(-)E4(+) adenovirus gene transfer vectors.
Ramalingam R; Worgall S; Rafii S; Crystal RG
Mol Ther; 2000 Oct; 2(4):381-6. PubMed ID: 11020354
[TBL] [Abstract][Full Text] [Related]
15. Designing E1 deleted adenoviral vector by homologous recombination.
Zamani A; Ghannad MS
Iran Biomed J; 2007 Jul; 11(3):199-202. PubMed ID: 18051781
[TBL] [Abstract][Full Text] [Related]
16. Persistent transgene expression in mouse liver following in vivo gene transfer with a delta E1/delta E4 adenovirus vector.
Wang Q; Greenburg G; Bunch D; Farson D; Finer MH
Gene Ther; 1997 May; 4(5):393-400. PubMed ID: 9274715
[TBL] [Abstract][Full Text] [Related]
17. The constitutive expression of the immunomodulatory gp19k protein in E1-, E3- adenoviral vectors strongly reduces the host cytotoxic T cell response against the vector.
Lee MG; Abina MA; Haddada H; Perricaudet M
Gene Ther; 1995 Jun; 2(4):256-62. PubMed ID: 7552985
[TBL] [Abstract][Full Text] [Related]
18. Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli.
Hoffmann D; Wildner O
BMC Biotechnol; 2006 Aug; 6():36. PubMed ID: 16887042
[TBL] [Abstract][Full Text] [Related]
19. Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted.
Amalfitano A; Hauser MA; Hu H; Serra D; Begy CR; Chamberlain JS
J Virol; 1998 Feb; 72(2):926-33. PubMed ID: 9444984
[TBL] [Abstract][Full Text] [Related]
20. Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit.
Yeh P; Dedieu JF; Orsini C; Vigne E; Denefle P; Perricaudet M
J Virol; 1996 Jan; 70(1):559-65. PubMed ID: 8523570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
